查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1750634

卵巢治療市場規模、佔有率、趨勢分析報告：按藥物類別、程序、分銷管道、地區和細分市場進行預測（2025-2030 年）

Polycystic Ovarian Syndrome Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Surgery, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

卵巢症候群治療市場的成長和趨勢：

根據 Grand View Research, Inc. 的新報告，全球卵巢治療市場預計到 2030 年將達到 69.9 億美元，2025 年至 2030 年的複合年成長率為 6.6%。

根據美國疾病管制與預防中心 (CDC) 的數據，卵巢症候群 (PCOS) 是女性不孕症最常見的原因。美國育齡女性中約有 6% 至 12% 患有 PCOS。此外，隨著病情發展，會出現代謝異常，而延誤治療則可能導致第 2 型糖尿病。 PCOS 的嚴重程度會增加患者罹患子宮癌和子宮內膜癌的風險。因此，早期診斷和有效治療對於患者的康復至關重要。

目前，市面上尚無針對該疾病的特效療法。因此，治療的主要目的是治療方法。由於此症候群的症狀各異，因此需要使用不同類別/組合的藥物進行治療。因此，市場領導者正致力於開發針對該疾病根源的特定藥物/治療方法。Astra Zeneca是參與開發此類藥物的領導企業之一。

卵巢治療市場報告重點

  • 根據藥物類別，胰島素增敏劑將佔據市場主導地位，到 2024 年將佔 36.0% 的佔有率。
  • 以手術方式計算，卵巢楔形切除術預計在預測期內將以顯著的複合年成長率成長。
  • 根據銷售管道，預計線上供應商部門在預測期內將實現最快的複合年成長率。
  • 預計亞太卵巢治療市場在預測期內將實現最快的複合年成長率。

目錄

第1章調查方法與範圍

第2章執行摘要

3.卵巢治療市場變數、趨勢和範圍

  • 市場介紹/電網展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 卵巢治療市場分析工具
    • 波特的分析
    • PESTEL分析

第4章卵巢治療市場：藥物類別估計與趨勢分析

  • 細分儀表板
  • 卵巢治療市場：2024 年和 2030 年藥物類別變化分析
  • 口服避孕藥
  • 抗雄激素
  • 胰島素增敏劑
  • 抗憂鬱症
  • 肥胖預防

第5章卵巢治療市場：手術估計與趨勢分析

  • 細分儀表板
  • 卵巢治療市場：2024 年和 2030 年手術變異分析
  • 卵巢楔形切除術
  • 腹腔鏡卵巢打孔術

第6章卵巢治療市場：通路評估與趨勢分析

  • 細分儀表板
  • 卵巢治療市場：2024 年和 2030 年分銷管道變化分析
  • 院內藥房
  • 藥局和零售藥局
  • 線上提供者

第7章卵巢治療市場：區域估計與趨勢分析

  • 2024 年及 2030 年多卵巢症候群治療市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • AstraZeneca
    • Bayer AG
    • Merck KGaA.
    • Abbott
    • Pfizer, Inc
    • Sanofi
    • Bristol Myers Squibb Company
    • Teva Pharmaceutical Industries Ltd
    • Novartis AG
    • Ferring BV
Product Code: GVR-2-68038-203-7

Polycystic Ovarian Syndrome Treatment Market Growth & Trends:

The global polycystic ovarian syndrome treatment market size is estimated to reach USD 6.99 billion by 2030, registering a CAGR of 6.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. According to the Centers of Disease Control & Prevention (CDC), Polycystic Ovary Syndrome (PCOS) is the most common cause of female infertility. Approximately 6% to 12% women of reproductive age suffer from PCOS in the U. S. Moreover, progression of this condition can lead to metabolic abnormalities, which may result in development of type 2 diabetes, if the syndrome is not treated on time. The severity of the disorder increases the risk of developing uterine and endometrial cancers in patients. Thus, early diagnosis and effective treatment are significant for successful recovery.

Presently, no specific drug is commercially available for this condition. Thus, treating symptoms is the prime aim of the treatment regimen. Owing to the various symptoms associated with this syndrome, a range of drug class/combinations is used in the treatment. Therefore, market leaders are focusing on developing a specific drug/treatment to cure the root cause of this disease. AstraZeneca is one of the leaders involved in developing such a drug.

Polycystic Ovarian Syndrome Treatment Market Report Highlights:

  • Based on drug class, the insulin-sensitizing agents dominated the market and accounted for a share of 36.0% in 2024.
  • By surgery, the ovarian wedge resection segment is expected to grow at a significant CAGR over the forecast period.
  • Based on the distribution channel, the online providers segment is expected to register the fastest CAGR during the forecast period.
  • Asia Pacific's polycystic ovarian syndrome treatment market is estimated to register the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Polycystic Ovarian Syndrome Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Polycystic Ovarian Syndrome Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Polycystic Ovarian Syndrome Treatment Market: Drug Class Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Polycystic Ovarian Syndrome Treatment Market:, Drug Class Movement Analysis, 2024 & 2030 (USD Billion)
  • 4.3. Oral Contraceptives
    • 4.3.1. Oral Contraceptives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Antiandrogens
    • 4.4.1. Antiandrogens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Insulin-sensitizing Agent
    • 4.5.1. Insulin-sensitizing Agent Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Antidepressant
    • 4.6.1. Antidepressant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.7. Anti-obesity
    • 4.7.1. Anti-obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Polycystic Ovarian Syndrome Treatment Market: Surgery Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Polycystic Ovarian Syndrome Treatment Market: Surgery Movement Analysis, 2024 & 2030 (USD Billion)
  • 5.3. Ovarian Wedge Resection
    • 5.3.1. Ovarian Wedge Resection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Laparoscopic Ovarian Drilling
    • 5.4.1. Laparoscopic Ovarian Drilling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Polycystic Ovarian Syndrome Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Polycystic Ovarian Syndrome Treatment Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Billion)
  • 6.3. Hospital Pharmacy
    • 6.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Drug Store & Retail Pharmacy
    • 6.4.1. Drug Store & Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Online Providers
    • 6.5.1. Online Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Polycystic Ovarian Syndrome Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Polycystic Ovarian Syndrome Treatment Market Share, By Region, 2024 & 2030 (USD Billion)
  • 7.2. North America
    • 7.2.1. North America Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.2. U.S.
    • 7.2.3. U.S. Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.4. Canada
      • 7.2.4.1. Canada Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.5. Mexico
      • 7.2.5.1. Mexico Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.3. Europe
    • 7.3.1. Europe Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.2. UK
      • 7.3.2.1. UK Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.4. France
      • 7.3.4.1. France Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.2. China
      • 7.4.2.1. China Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.4. India
      • 7.4.4.1. India Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Latin America
    • 7.5.1. Latin America Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. AstraZeneca
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Bayer AG
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Merck KGaA.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Abbott
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Pfizer, Inc
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Sanofi
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Bristol Myers Squibb Company
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Teva Pharmaceutical Industries Ltd
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Novartis AG
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Ferring B.V.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Leading Market Players Anticipated to Witness Highest Growth
  • Table 4. Global polycystic ovarian syndrome treatment market, By Region, 2018 - 2030 (USD Billion)
  • Table 5. Global polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 6. Global polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 7. Global polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 8. North America polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 9. North America polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 10. North America polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 11. North America polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 12. U.S. polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 13. U.S. polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 14. U.S. polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 15. Canada polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 16. Canada polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 17. Canada polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 18. Mexico polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 19. Mexico polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 20. Mexico polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 21. Europe polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 22. Europe polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 23. Europe polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 24. Europe polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 25. UK polycystic ovarian syndrome treatment market, By, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 26. UK polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 27. UK polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28. Germany polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 29. Germany polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 30. Germany polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 31. France polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 32. France polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 33. France polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 34. Italy polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 35. Italy polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 36. Italy polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 37. Spain polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 38. Spain polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 39. Spain polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40. Denmark polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 41. Denmark polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 42. Denmark polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 43. Sweden polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 44. Sweden polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 45. Sweden polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 46. Norway polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 47. Norway polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 48. Norway polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 49. Asia Pacific polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 50. Asia Pacific polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 51. Asia Pacific polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52. Asia Pacific polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 53. Japan polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 54. Japan polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 55. Japan polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 56. China polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 57. China polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 58. China polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 59. India polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 60. India polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 61. India polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 62. South Korea polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 63. South Korea polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 64. South Korea polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 65. Australia polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 66. Australia polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 67. Australia polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 68. Thailand polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 69. Thailand polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 70. Thailand polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 71. Latin America polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 72. Latin America polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 73. Latin America polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 74. Latin America polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 75. Brazil polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 76. Brazil polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 77. Brazil polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 78. Argentina polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 79. Argentina polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 80. Argentina polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 81. Middle East and Africa polycystic ovarian syndrome treatment market, By Country, 2018 - 2030 (USD Billion)
  • Table 82. Middle East and Africa polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 83. Middle East and Africa polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 84. Middle East & Africa polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 85. South Africa polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 86. South Africa polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 87. South Africa polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 88. Saudi Arabia polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 89. Saudi Arabia polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 90. Saudi Arabia polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 91. UAE polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 92. UAE polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 93. UAE polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 94. Kuwait polycystic ovarian syndrome treatment market, By Drug Class, 2018 - 2030 (USD Billion)
  • Table 95. Kuwait polycystic ovarian syndrome treatment market, By Surgery, 2018 - 2030 (USD Billion)
  • Table 96. Kuwait polycystic ovarian syndrome treatment market, By Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Polycystic ovarian syndrome treatment market segment scope and defination
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Polycystic ovarian syndrome treatment market:, By Drug Class movement analysis
  • Fig. 17 Polycystic ovarian syndrome treatment market:, By Drug Class segment dashboard
  • Fig. 18 Polycystic ovarian syndrome treatment market, By Drug Class outlook: Key takeaways
  • Fig. 19 Luminometric Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Enzymatic Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Bioluminescence Resonance Energy Transfer (BRET) Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Cell-based Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Anti-obesity Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Polycystic ovarian syndrome treatment market: Surgery movement analysis
  • Fig. 25 Polycystic ovarian syndrome treatment market Surgery outlook: Key takeaways
  • Fig. 26 Ovarian Wedge Resection Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Laparoscopic Ovarian Drilling Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Food Safety and Quality TestingPolycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Other Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Polycystic ovarian syndrome treatment market: Distribution Channel movement analysis
  • Fig. 32 Polycystic ovarian syndrome treatment market Distribution Channel outlook: Key takeaways
  • Fig. 33 Hospital Pharmacy Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Drug Store & Retail Pharmacy Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Online Providers Polycystic ovarian syndrome treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Regional outlook, 2024 & 2030
  • Fig. 37 Regional market dashboard
  • Fig. 38 Regional market place: Key takeaways
  • Fig. 39 North America polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 40 U.S. polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 42 Mexico polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 43 Europe polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 44 UK polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 45 Germany polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 46 Spain polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 47 France polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 48 Italy implantable Market, 2018 - 2030 (USD Billion)
  • Fig. 49 Denmark polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 50 Sweden polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 51 Norway polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 52 Asia Pacific polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 53 Japan polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 54 China polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 55 India polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 56 South Korea polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 57 Australia polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 58 Thailand polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 59 Latin America polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 60 Brazil polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 61 Argentina polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 62 MEA polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 63 South Africa polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 64 Saudi Arabia polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 66 Kuwait polycystic ovarian syndrome treatment market, 2018 - 2030 (USD Billion)
  • Fig. 67 Heat map analysis
  • Fig. 68 Market differentiators